← Back
$AMLX All transactions

Amylyx Pharmaceuticals, Inc.

▼ SELL

$ Value

$155K

Shares

10,558

Price

$15

Filed

Oct 2

Insider

Name

FRATES JAMES M

Title

Chief Financial Officer

CIK

0001235598

Roles

Officer

Transaction Details

Transaction Date

2025-09-30

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

280,430

Footnotes

Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.35 to $15.075. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. | Shares held by the James M. Frates 2024 Grantor Retained Annuity Trust No. 1, for which the Reporting Person serves as trustee and is the sole annuitant. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose. | Shares held by the FRATES FAMILY 2013 IRREV TRUST, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

Filing Info

Accession No.

0001193125-25-228341

Form Type

4

Issuer CIK

0001658551

FRATES JAMES M's History

Date Ticker Type Value
2026-03-05 AMLX A $0
2026-03-05 AMLX A $0
2026-03-02 AMLX $115K
2026-02-02 AMLX $52K
2026-01-06 AMLX $37K
2025-09-30 AMLX $155K
2025-07-31 SAGE U
2025-07-31 SAGE D
2025-07-31 SAGE D
2025-06-11 SAGE A $0

Other Insiders at AMLX (90d)

Insider Bought Sold Last
FRATES JAMES M
Chief Financial Officer
$167K 2026-03-05
Bedrosian Camille L
Chief Medical Officer
$94K 2026-03-05
Klee Justin B.
Co-Chief Executive Officer
$651K 2026-03-05
Cohen Joshua B
Co-Chief Executive Officer
$652K 2026-03-05
Mazzariello Gina
Chief Legal Officer
$198K 2026-03-05